DrugPatentWatch Database Preview
Genus Company Profile
» See Plans and Pricing
What is the competitive landscape for GENUS, and what generic alternatives to GENUS drugs are available?
GENUS has eleven approved drugs.
There are seventeen US patents protecting GENUS drugs.
There are eighty patent family members on GENUS drugs in twenty-eight countries and twenty-five supplementary protection certificates in thirteen countries.
Summary for Genus
| International Patents: | 80 |
| US Patents: | 17 |
| Tradenames: | 10 |
| Ingredients: | 10 |
| NDAs: | 11 |
Drugs and US Patents for Genus
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Genus Lifesciences | YOSPRALA | aspirin; omeprazole | TABLET, DELAYED RELEASE;ORAL | 205103-002 | Sep 14, 2016 | DISCN | Yes | No | 8,206,741 | Get Started for $10 | Y | Get Started for $10 | |||
| Genus Lifesciences | YOSPRALA | aspirin; omeprazole | TABLET, DELAYED RELEASE;ORAL | 205103-002 | Sep 14, 2016 | DISCN | Yes | No | 9,539,214 | Get Started for $10 | Get Started for $10 | ||||
| Genus Lifesciences | POTASSIUM CHLORIDE | potassium chloride | SOLUTION;ORAL | 206814-002 | Dec 22, 2014 | AA | RX | Yes | Yes | Get Started for $10 | Get Started for $10 | ||||
| Genus Lifesciences | LEVOLET | levothyroxine sodium | TABLET;ORAL | 021137-003 | Jun 6, 2003 | DISCN | No | No | Get Started for $10 | Get Started for $10 | |||||
| Genus Lifesciences | LEVOLET | levothyroxine sodium | TABLET;ORAL | 021137-004 | Jun 6, 2003 | DISCN | No | No | Get Started for $10 | Get Started for $10 | |||||
| Genus Lifesciences | OXYCODONE HYDROCHLORIDE | oxycodone hydrochloride | SOLUTION;ORAL | 200535-002 | Aug 22, 2013 | AA | RX | Yes | No | Get Started for $10 | Get Started for $10 | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Paragraph IV (Patent) Challenges for GENUS drugs
| Drugname | Dosage | Strength | Tradename | Submissiondate |
|---|---|---|---|---|
| ➤ Subscribe | Delayed-release Tablets | 81 mg/40 mg | ➤ Subscribe | 2016-10-14 |
International Patents for Genus Drugs
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| European Patent Office | 2421513 | Get Started for $10 |
| Mexico | 351930 | Get Started for $10 |
| Japan | 4756823 | Get Started for $10 |
| Morocco | 32692 | Get Started for $10 |
| Spain | 2348710 | Get Started for $10 |
| Ukraine | 115139 | Get Started for $10 |
| >Country | >Patent Number | >Estimated Expiration |
Supplementary Protection Certificates for Genus Drugs
| Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
|---|---|---|---|---|
| 1411900 | C300481 | Netherlands | Get Started for $10 | PRODUCT NAME: NAPROXEN EN ESOMEPRAZOL; NAT. REGISTRATION NO/DATE: RVG 106235 20101118; FIRST REGISTRATION: PL 17901/0263-001 20101105 |
| 1411900 | SPC/GB11/015 | United Kingdom | Get Started for $10 | PRODUCT NAME: NAPROXEN AND ESOMEPRAZOLE; REGISTERED: UK PL 17901/0263-0001 20101105 |
| 1685839 | 92292 | Luxembourg | Get Started for $10 | PRODUCT NAME: COMBINAISON D OXYCODONE EN TANT QUE COMPOSANT A ET DE NALOXONE EN TANT QUE COMPOSANT B SOUS TOUTES LES FORMES PROTEGES PAR LE BREVET DE BASE |
| 0480717 | 98C0025 | Belgium | Get Started for $10 | PRODUCT NAME: LOSARTAN POTASSIUM; HYDROCHLOROTHIAZIDE; NAT. REGISTRATION NO/DATE: NL 20 037 19950215; FIRST REGISTRATION: FR - NL 20 037 19950215 |
| 1411900 | 435 | Finland | Get Started for $10 | |
| 1411900 | 2011C/016 | Belgium | Get Started for $10 | DETAILS ASSIGNMENT: CHANGE OF OWNER(S), CESSION |
| >Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
